Figure 4. Survival curve results of different expression levels of FZD1 on prognosis of ccRCC patients. (A) Total ROC curve of FZD1 in renal carcinoma. (B) Nomograms were used to predict 1-year, 3-year, and 5-year OS for the entire TCGA cohort; (C) Calibration curves for predicting OS; (D-F) Time dependent on AUC 1, 3 and 5 year OS, DSS and PFI; Subgroup ROC curve of (G-K) FZD1 in renal carcinoma. (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

From

FZD1: As a Novel Prognostic Marker for Renal Clear Cell Carcinoma, is Associated with Tumor Immunoinfiltration

Min Luo, Yin Wang, Pei Feng Li

Journal of Food and Nutrition Research. 2024, 12(3), 151-159 doi:10.12691/jfnr-12-3-7